1. Home
  2. WVE vs LMND Comparison

WVE vs LMND Comparison

Compare WVE & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • LMND
  • Stock Information
  • Founded
  • WVE 2012
  • LMND 2015
  • Country
  • WVE Singapore
  • LMND United States
  • Employees
  • WVE N/A
  • LMND N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • LMND Property-Casualty Insurers
  • Sector
  • WVE Health Care
  • LMND Finance
  • Exchange
  • WVE Nasdaq
  • LMND Nasdaq
  • Market Cap
  • WVE 2.4B
  • LMND 2.0B
  • IPO Year
  • WVE 2015
  • LMND 2020
  • Fundamental
  • Price
  • WVE $13.67
  • LMND $33.30
  • Analyst Decision
  • WVE Strong Buy
  • LMND Hold
  • Analyst Count
  • WVE 10
  • LMND 6
  • Target Price
  • WVE $21.30
  • LMND $24.60
  • AVG Volume (30 Days)
  • WVE 1.4M
  • LMND 2.4M
  • Earning Date
  • WVE 11-12-2024
  • LMND 10-30-2024
  • Dividend Yield
  • WVE N/A
  • LMND N/A
  • EPS Growth
  • WVE N/A
  • LMND N/A
  • EPS
  • WVE N/A
  • LMND N/A
  • Revenue
  • WVE $53,610,000.00
  • LMND $492,500,000.00
  • Revenue This Year
  • WVE N/A
  • LMND N/A
  • Revenue Next Year
  • WVE N/A
  • LMND $26.74
  • P/E Ratio
  • WVE N/A
  • LMND N/A
  • Revenue Growth
  • WVE N/A
  • LMND 22.09
  • 52 Week Low
  • WVE $3.50
  • LMND $14.03
  • 52 Week High
  • WVE $16.74
  • LMND $35.17
  • Technical
  • Relative Strength Index (RSI)
  • WVE 50.96
  • LMND 75.00
  • Support Level
  • WVE $14.95
  • LMND $31.41
  • Resistance Level
  • WVE $16.71
  • LMND $34.95
  • Average True Range (ATR)
  • WVE 1.04
  • LMND 2.44
  • MACD
  • WVE -0.28
  • LMND 0.89
  • Stochastic Oscillator
  • WVE 14.72
  • LMND 89.17

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.

Share on Social Networks: